Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD

View at Publisher

Ask AI

Bookmark

Share

Key Points

This commentary aims to evaluate the consensus guidelines provided by the American Society of Clinical Psychopharmacology regarding stimulant deprescribing for adults with ADHD.
Review of the task force consensus statement on deprescribing stimulant medications for ADHD.
Analysis of recommendations for clinical practice in managing adult ADHD treatment.
Evaluation of potential implications for patient care and safety.
Identified gaps in the current guidelines that may impact effective deprescribing practices.
Suggested additional considerations for practitioners when deprescribing stimulant medications.
Highlighted the need for more comprehensive patient-specific approaches in clinical guidelines.

We only have this paper's title and publication details.

Commentary reviews clinical guidelines for deprescribing stimulant medications in adults with ADHD, suggesting improvements for patient outcomes.

No takes yet. Share an insight, caveat, or question.

Crunelle et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share